260 related articles for article (PubMed ID: 24836066)
1. Antiproliferative novel isoxazoles: modeling, virtual screening, synthesis, and bioactivity evaluation.
Tzanetou E; Liekens S; Kasiotis KM; Melagraki G; Afantitis A; Fokialakis N; Haroutounian SA
Eur J Med Chem; 2014 Jun; 81():139-49. PubMed ID: 24836066
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel 1,2,3-triazole/isoxazole functionalized 2H-Chromene derivatives and their cytotoxic activity.
Ratnakar Reddy K; Sambasiva Rao P; Jitender Dev G; Poornachandra Y; Ganesh Kumar C; Shanthan Rao P; Narsaiah B
Bioorg Med Chem Lett; 2014 Apr; 24(7):1661-3. PubMed ID: 24641975
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 4-arylamido 3-methyl isoxazole derivatives as novel FMS kinase inhibitors.
Im D; Jung K; Yang S; Aman W; Hah JM
Eur J Med Chem; 2015 Sep; 102():600-10. PubMed ID: 26318067
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of pyrazole/isoxazole linked arylcinnamides as tubulin polymerization inhibitors and potential antiproliferative agents.
Kamal A; Shaik AB; Rao BB; Khan I; Bharath Kumar G; Jain N
Org Biomol Chem; 2015 Oct; 13(40):10162-78. PubMed ID: 26303171
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel forskolin isoxazole derivatives with potent anti-cancer activity against breast cancer cell lines.
Burra S; Voora V; Rao CP; Vijay Kumar P; Kancha RK; David Krupadanam GL
Bioorg Med Chem Lett; 2017 Sep; 27(18):4314-4318. PubMed ID: 28838692
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
Kamal A; Bharathi EV; Reddy JS; Ramaiah MJ; Dastagiri D; Reddy MK; Viswanath A; Reddy TL; Shaik TB; Pushpavalli SN; Bhadra MP
Eur J Med Chem; 2011 Feb; 46(2):691-703. PubMed ID: 21194809
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel isoxazoles and triazoles linked 6-hydroxycoumarin as potent cytotoxic agents.
Shakeel-u-Rehman ; Masood-ur-Rahman ; Tripathi VK; Singh J; Ara T; Koul S; Farooq S; Kaul A
Bioorg Med Chem Lett; 2014 Sep; 24(17):4243-6. PubMed ID: 25088398
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxic activity evaluation of some novel 1-(3-(aryl-4,5-dihydroisoxazol-5-yl)methyl)-4-trihalomethyl-1H-pyrimidin-2-ones in human cancer cells.
Lobo MM; Viau CM; Dos Santos JM; Bonacorso HG; Martins MA; Amaral SS; Saffi J; Zanatta N
Eur J Med Chem; 2015 Aug; 101():836-42. PubMed ID: 26275603
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of new arenediyne-linked isoxazolidines.
Romeo R; Navarra M; Giofrè SV; Carnovale C; Cirmi S; Lanza G; Chiacchio MA
Bioorg Med Chem; 2014 Jul; 22(13):3379-85. PubMed ID: 24835789
[TBL] [Abstract][Full Text] [Related]
11. Exploration of isoxazole analogs: Synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling.
Hawash M; Abdallah S; Abudayyak M; Melhem Y; Abu Shamat M; Aghbar M; Çapan I; Abualhasan M; Kumar A; Kamiński M; Góral T; Dominiak PM; Sobuh S
Eur J Med Chem; 2024 May; 271():116397. PubMed ID: 38626522
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.
Rane RA; Sahu NU; Gutte SD; Mahajan AA; Shah CP; Bangalore P
Eur J Med Chem; 2013 May; 63():793-9. PubMed ID: 23584542
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
[TBL] [Abstract][Full Text] [Related]
14. Regioselective synthesis of 3,4-diaryl-5-unsubstituted isoxazoles, analogues of natural cytostatic combretastatin A4.
Chernysheva NB; Maksimenko AS; Andreyanov FA; Kislyi VP; Strelenko YA; Khrustalev VN; Semenova MN; Semenov VV
Eur J Med Chem; 2018 Feb; 146():511-518. PubMed ID: 29407976
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of some novel methyl β-orsellinate based 3, 5-disubstituted isoxazoles and their anti-proliferative activity: Identification of potent leads active against MCF-7 breast cancer cell.
Reddy ST; Mendonza JJ; Makani VKK; Bhadra MP; Uppuluri VM
Bioorg Chem; 2020 Dec; 105():104374. PubMed ID: 33130349
[TBL] [Abstract][Full Text] [Related]
16. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of pyridinyl-1H-1,2,3-triazolyldihydroisoxazoles as potent inhibitors of tubulin polymerization.
Suman P; Murthy TR; Rajkumar K; Srikanth D; Dayakar Ch; Kishor C; Addlagatta A; Kalivendi SV; Raju BC
Eur J Med Chem; 2015 Jan; 90():603-19. PubMed ID: 25499929
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents.
Çalışkan B; Sinoplu E; İbiş K; Akhan Güzelcan E; Çetin Atalay R; Banoglu E
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1352-1361. PubMed ID: 30251900
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel triazoles and isoxazoles linked 2-phenyl benzothiazole as potential anticancer agents.
Kumbhare RM; Kosurkar UB; Janaki Ramaiah M; Dadmal TL; Pushpavalli SN; Pal-Bhadra M
Bioorg Med Chem Lett; 2012 Sep; 22(17):5424-7. PubMed ID: 22858144
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biochemical evaluation of δ(2)-isoxazoline derivatives as DNA methyltransferase 1 inhibitors.
Castellano S; Kuck D; Viviano M; Yoo J; López-Vallejo F; Conti P; Tamborini L; Pinto A; Medina-Franco JL; Sbardella G
J Med Chem; 2011 Nov; 54(21):7663-77. PubMed ID: 21958292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]